McKesson (MCK) EBITDA Margin: History & Chart

McKesson Corporation (MCK)MCKMcKesson Corporation

About McKesson Corporation

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

Irving, TX

43,000 employees

www.mckesson.com

Healthcare / Medical - Distribution

Sector: Healthcare
Industry: Medical - Distribution
CEO: Brian S. Tyler

View full financials

MCK EBITDA Margin Metrics

EBITDA MARGIN

2.54%

EBITDA MARGIN AVG TTM

1.67%

EBITDA MARGIN AVG 3Y

1.48%

EBITDA MARGIN AVG 5Y

1.61%

EBITDA MARGIN AVG 10Y

1.78%

EBITDA MARGIN AVG 15Y

1.92%

EBITDA MARGIN AVG 20Y

1.92%

CURRENT VS TTM AVG

+51.58%

CURRENT VS 3Y AVG

+71.72%

CURRENT VS 5Y AVG

+57.34%

CURRENT VS 10Y AVG

+42.88%

CURRENT VS 15Y AVG

+31.92%

CURRENT VS 20Y AVG

+32.04%

NAME	MARKET CAP	EBITDA MARGIN	TTM	3Y	5Y
McKesson Corporation (MCK)	$97.23B	2.54%	1.67%	1.48%	1.61%
GSK plc (GSK)vs ›	$103.24B	32.61%	26.78%	28.16%	28.64%
HCA Healthcare, Inc. (HCA)vs ›	$86.76B	20.49%	20.06%	19.91%	20.05%
Medtronic plc (MDT)vs ›	$110.34B	25.92%	26.11%	25.62%	25.51%
Elevance Health Inc. (ELV)vs ›	$81.98B	4.85%	5.33%	5.81%	6.32%
Regeneron Pharmaceuticals, Inc. (REGN)vs ›	$78.36B	28.74%	30.12%	35.91%	41.00%
Boston Scientific Corporation (BSX)vs ›	$72.97B	26.60%	24.95%	24.24%	23.28%
Vertex Pharmaceuticals Incorporated (VRTX)vs ›	$121.50B	41.14%	20.45%	32.86%	36.27%
Cigna Corporation (CI)vs ›	$72.42B	4.28%	4.40%	4.95%	5.27%
Stryker Corporation (SYK)vs ›	$128.79B	24.22%	25.63%	25.70%	26.23%

NAME

MARKET CAP

EBITDA MARGIN

TTM

McKesson Corporation (MCK)

$97.23B

2.54%

1.67%

1.48%

1.61%

GSK plc (GSK)vs ›

$103.24B

32.61%

26.78%

28.16%

28.64%

HCA Healthcare, Inc. (HCA)vs ›

$86.76B

20.49%

20.06%

19.91%

20.05%

Medtronic plc (MDT)vs ›

$110.34B

25.92%

26.11%

25.62%

25.51%

Elevance Health Inc. (ELV)vs ›

$81.98B

4.85%

5.33%

5.81%

6.32%

Regeneron Pharmaceuticals, Inc. (REGN)vs ›

$78.36B

28.74%

30.12%

35.91%

41.00%

Boston Scientific Corporation (BSX)vs ›

$72.97B

26.60%

24.95%

24.24%

23.28%

Vertex Pharmaceuticals Incorporated (VRTX)vs ›

$121.50B

41.14%

20.45%

32.86%

36.27%

Cigna Corporation (CI)vs ›

$72.42B

4.28%

4.40%

4.95%

5.27%

Stryker Corporation (SYK)vs ›

$128.79B

24.22%

25.63%

25.70%

26.23%

EBITDA Margin FAQ

What is the EBITDA margin for McKesson Corporation (MCK)?

The EBITDA margin for MCK stock is 2.54%.

Is McKesson Corporation's EBITDA margin high or low?

The EBITDA margin of 2.54% is 57% above its 5-year average of 1.61%, near the high end of its 5-year range (0.81%–2.54%).

What is the TTM average EBITDA margin for McKesson Corporation (MCK)?

The TTM average EBITDA margin for MCK stock is 1.67%.

What is the 3Y average EBITDA margin for McKesson Corporation (MCK)?

The 3Y average EBITDA margin for MCK stock is 1.48%.

What is the 5Y average EBITDA margin for McKesson Corporation (MCK)?

The 5Y average EBITDA margin for MCK stock is 1.61%.

What is the 10Y average EBITDA margin for McKesson Corporation (MCK)?

The 10Y average EBITDA margin for MCK stock is 1.78%.

What is the 15Y average EBITDA margin for McKesson Corporation (MCK)?

The 15Y average EBITDA margin for MCK stock is 1.92%.

What is the 20Y average EBITDA margin for McKesson Corporation (MCK)?

The 20Y average EBITDA margin for MCK stock is 1.92%.

DATE	EBITDA MARGIN
2026-03-31	2.54%
2025-12-31	1.70%
2025-09-30	1.61%
2025-06-30	1.22%
2025-03-31	1.31%
2024-12-31	1.51%
2024-09-30	0.97%
2024-06-30	1.55%
2024-03-31	2.01%
2023-12-31	0.97%
2023-09-30	1.37%
2023-06-30	1.60%
2023-03-31	1.93%
2022-12-31	1.91%
2022-09-30	1.94%
2022-06-30	1.90%
2022-03-31	1.50%
2021-12-31	0.81%
2021-09-30	1.41%
2021-06-30	1.77%
2021-03-31	2.37%
2020-12-31	1.94%
2020-09-30	1.83%
2020-06-30	1.70%
2020-03-31	2.46%
2019-12-31	1.23%
2019-09-30	1.57%
2019-06-30	1.59%
2019-03-31	2.13%
2018-12-31	1.69%
2018-09-30	1.90%
2018-06-30	1.62%
2018-03-31	1.96%
2017-12-31	1.80%
2017-09-30	2.04%
2017-06-30	1.63%
2017-03-31	1.97%
2016-12-31	2.22%
2016-09-30	2.23%
2016-06-30	2.44%
2016-03-31	2.04%
2015-12-31	2.38%
2015-09-30	2.41%
2015-06-30	2.44%
2015-03-31	2.06%
2014-12-31	2.19%
2014-09-30	2.34%
2014-06-30	2.21%
2014-03-31	2.06%
2013-12-31	1.88%
2013-09-30	2.55%
2013-06-30	2.49%
2013-03-31	2.62%
2012-12-31	2.02%
2012-09-30	2.52%
2012-06-30	2.33%
2012-03-31	2.68%
2011-12-31	2.04%
2011-09-30	2.03%
2011-06-30	2.02%
2011-03-31	2.22%
2010-12-31	1.49%
2010-09-30	1.94%
2010-06-30	2.16%
2010-03-31	2.62%
2009-12-31	2.25%
2009-09-30	2.14%
2009-06-30	2.14%
2009-03-31	2.32%
2008-12-31	0.21%
2008-09-30	1.86%
2008-06-30	1.79%
2008-03-31	2.21%
2007-12-31	1.42%
2007-09-30	1.83%
2007-06-30	1.81%
2007-03-31	1.88%
2006-12-31	1.67%
2006-09-30	1.68%
2006-06-30	1.45%
2006-03-31	1.76%
2005-12-31	1.61%
2005-09-30	1.35%
2005-06-30	1.54%
2005-03-31	2.19%
2004-12-31	-4.35%
2004-09-30	0.96%
2004-06-30	1.68%
2004-03-31	2.29%
2003-12-31	0.12%
2003-09-30	1.67%
2003-06-30	1.84%
2003-03-31	2.34%
2002-12-31	1.74%
2002-09-30	1.97%
2002-06-30	1.87%

DATE

EBITDA MARGIN

2026-03-31

2.54%

2025-12-31

1.70%

2025-09-30

1.61%

2025-06-30

1.22%

2025-03-31

1.31%

2024-12-31

1.51%

2024-09-30

0.97%

2024-06-30

1.55%

2024-03-31

2.01%

2023-12-31

0.97%

2023-09-30

1.37%

2023-06-30

1.60%

2023-03-31

1.93%

2022-12-31

1.91%

2022-09-30

1.94%

2022-06-30

1.90%

2022-03-31

1.50%

2021-12-31

0.81%

2021-09-30

1.41%

2021-06-30

1.77%

2021-03-31

2.37%

2020-12-31

1.94%

2020-09-30

1.83%

2020-06-30

1.70%

2020-03-31

2.46%

2019-12-31

1.23%

2019-09-30

1.57%

2019-06-30

1.59%

2019-03-31

2.13%

2018-12-31

1.69%

2018-09-30

1.90%

2018-06-30

1.62%

2018-03-31

1.96%

2017-12-31

1.80%

2017-09-30

2.04%

2017-06-30

1.63%

2017-03-31

1.97%

2016-12-31

2.22%

2016-09-30

2.23%

2016-06-30

2.44%

2016-03-31

2.04%

2015-12-31

2.38%

2015-09-30

2.41%

2015-06-30

2.44%

2015-03-31

2.06%

2014-12-31

2.19%

2014-09-30

2.34%

2014-06-30

2.21%

2014-03-31

2.06%

2013-12-31

1.88%

2013-09-30

2.55%

2013-06-30

2.49%

2013-03-31

2.62%

2012-12-31

2.02%

2012-09-30

2.52%

2012-06-30

2.33%

2012-03-31

2.68%

2011-12-31

2.04%

2011-09-30

2.03%

2011-06-30

2.02%

2011-03-31

2.22%

2010-12-31

1.49%

2010-09-30

1.94%

2010-06-30

2.16%

2010-03-31

2.62%

2009-12-31

2.25%

2009-09-30

2.14%

2009-06-30

2.14%

2009-03-31

2.32%

2008-12-31

0.21%

2008-09-30

1.86%

2008-06-30

1.79%

2008-03-31

2.21%

2007-12-31

1.42%

2007-09-30

1.83%

2007-06-30

1.81%

2007-03-31

1.88%

2006-12-31

1.67%

2006-09-30

1.68%

2006-06-30

1.45%

2006-03-31

1.76%

2005-12-31

1.61%

2005-09-30

1.35%

2005-06-30

1.54%

2005-03-31

2.19%

2004-12-31

-4.35%

2004-09-30

0.96%

2004-06-30

1.68%

2004-03-31

2.29%

2003-12-31

0.12%

2003-09-30

1.67%

2003-06-30

1.84%

2003-03-31

2.34%

2002-12-31

1.74%

2002-09-30

1.97%

2002-06-30

1.87%

EBITDA Margin: 2.54%

MCK EBITDA Margin

MCK Average EBITDA Margin Chart

MCK Current vs Average EBITDA Margin Chart

MCK EBITDA Margin Metrics

MCK Competitors' EBITDA Margin

Margin Comparison

EBITDA Margin Formula & Definition

EBITDA Margin FAQ

MCK EBITDA Margin History

Related Metrics